Home›Companies›Tympanogen

Tympanogen, Inc.

Updated Oct 29, 2026·Latest SEC filing Mar 13, 2025·Suggest an edit

About Tympanogen

Tympanogen is a private company based in Richmond, Virginia. It has reported $2,180,653 raised in three offerings on Form D since March 2022. Its chief executive is Elaine Horn-Ranney.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 10, 2025Mar 13, 2025$1,155,653of $5.0M target33$35,020EquityRule 506(b)Form D ↗
Apr 28, 2023May 3, 2023$25,000of $1.0M target1$25,000Debt, OptionsRule 506(b)Form D ↗
Oct 8, 2021Mar 9, 2022$1,000,000of $2.5M target12$83,333Debt, OptionsRule 506(b)Form D ↗
Total, three offerings$2,180,653

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Tympanogen's Form D filed Mar 13, 2025.

ER
Elaine Horn-Ranney
CEO and director

Sources

  1. SECTympanogen, Inc. filing history